In many cancer types, TLS maturation status, commonly assessed by DC-LAMP positivity or the presence of CD21+ FDC network and a CD23+ Germinal Centre, is described as one of the main drivers of TLS prognostic value (8, 9). Here, CR2 is linked to cancer.